Vir Biotechnology, Inc. VIR
12.21 USD +1.19 (+10.80%)
At closeNov 6, 2026, 7:45 PM EST
12.32 +0.11 +0.91%
After hours · Nov 6, 7:45 PM ET
11.30 Day range 12.45
5.12 52-week range 12.21
- YTD
- +102.49%
- 1 year
- +138.48%
Held by funds
143 US ETFs and mutual funds hold VIR · largest positions
Ownership
Held by insiders 6.50%
Held by institutions 84.41%
Float held by institutions 90.28%
Institutions 353
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.07% | 20,678,283 | 252.48M | Jun 29, 2026 |
| Arch Venture Management, Llc | 7.41% | 12,694,163 | 155.00M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.71% | 11,495,215 | 140.36M | Jun 29, 2026 |
| SB Investment Advisers (UK) LTD | 6.39% | 10,948,093 | 133.68M | Jun 29, 2026 |
| State Street Corporation | 5.82% | 9,964,151 | 121.66M | Jun 29, 2026 |
| GSK plc | 4.99% | 8,550,954 | 104.41M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.83% | 4,846,948 | 59.18M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.06% | 3,533,092 | 43.14M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.03% | 3,476,669 | 42.45M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.49% | 2,546,144 | 31.09M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.17% | 1,996,625 | 24.38M | Jun 29, 2026 |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 1.03% | 1,762,412 | 21.52M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DE BACKER MARIANNE | Chief Executive Officer | Sale | Apr 5, 2026 | 1,001,260 |
| DE VERNEUIL VANINA ALEXANDRA HUARD | General Counsel | Sale | Nov 2, 2026 | 110,193 |
| EISNER MARK E | Officer | Sale | Feb 24, 2026 | 154,024 |
| HANLY ANN M | Chief Technology Officer | Sale | Feb 23, 2025 | 117,901 |
| MORE ROBERT J | Director | Stock Award(Grant) | May 26, 2026 | 558,573 |
| O'BYRNE JASON | Chief Financial Officer | Sale | Feb 23, 2026 | 162,615 |
